Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
179 words
A psychotropic pharmaceutical composition, which comprises as an active constituent, a therapeutically effective amount of a deuterated phenylhydantoin corresponding to the formula ##STR5## wherein R 1 , which may be the same or different, represents hydrogen or methyl, R 2 is ethyl, unsubstituted phenyl or phenyl substituted by halogen, straight chain or branched chain alkyl comprising 1 to 4 carbon atoms, straight or branched chain alkoxy comprising 1 to 4 carbon atoms, trifluoromethyl, nitro or amino, which phenyl or substituted phenyl may be deuterated, R 3 is hydrogen, halogen, straight chain or branched chain alkyl comprising 1 to 4 carbon atoms, straight or branched chain alkoxy comprising 1 to 4 carbon atoms, trifluoromethyl, nitro or amino, X is oxo, thio or methylene and x is an integer, with the proviso that the deuteration in R 2 and due to d x is such that said deuterated phenylhydantoin corresponding to the formula (I) is a mono- or penta-deuterated phenylhydantoin, one of its enantiomers or one of its salts with a physiologically acceptable base, in combination with a pharmaceutically acceptable vehicle.
Claim 2
Dependent Claim
179 words
A psychotropic pharmaceutical composition, which comprises as an active constituent, a therapeutically effective amount of a deuterated phenylhydantoin corresponding to the formula ##STR5## wherein R 1 , which may be the same or different, represents hydrogen or methyl, R 2 is ethyl, unsubstituted phenyl or phenyl substituted by halogen, straight chain or branched chain alkyl comprising 1 to 4 carbon atoms, straight or branched chain alkoxy comprising 1 to 4 carbon atoms, trifluoromethyl, nitro or amino, which phenyl or substituted phenyl may be deuterated, R 3 is hydrogen, halogen, straight chain or branched chain alkyl comprising 1 to 4 carbon atoms, straight or branched chain alkoxy comprising 1 to 4 carbon atoms, trifluoromethyl, nitro or amino, X is oxo, thio or methylene and x is an integer, with the proviso that the deuteration in R 2 and due to d x is such that said deuterated phenylhydantoin corresponding to the formula (I) is a mono- or penta-deuterated phenylhydantoin, one of its enantiomers or one of its salts with a physiologically acceptable base, in combination with a pharmaceutically acceptable vehicle.
Claim 3
Dependent Claim
51 words
A composition according to claim 1, wherein the phenylhydantoin is a deuterated diphenylhydantoin of the formula: ##STR6## wherein R 3 , which may be the same or different has the same meaning as defined in claim 1, R 1 and X are as defined in claim 1 and x+y=1 or 5.
Claim 4
Dependent Claim
27 words
A composition according to either of claims 1 or 2, wherein, in formulae I or II, said halogen for R 3 is chlorine, fluorine, bromine or iodine.
Claim 5
Dependent Claim
21 words
A composition according to claim 2, wherein said deuterated diphenylhydantoin is selected from the group consisting of (R,S)-5-(paradeuterophenyl)-5-phenylhydantoin, (R)-5-(paradeuterophenyl)-5-phenylhydantoin and (S)-5-(paradeuterophenyl)-5-phenylhydantoin.
Claim 6
Dependent Claim
27 words
A composition according to claim 2, wherein said deuterated diphenylhydantoin is selected from the group consisting of (R,S)-5-phenyl-d 5 -5-phenylhydantoin, (R)-5-phenyl-d 5 -5-phenylhydantoin and (S)-5-phenyl-d 5 -5-phenylhydantoin.
Claim 7
Dependent Claim
13 words
A composition according to claim 1, in the form of a unit dosage.
Claim 8
Dependent Claim
18 words
A composition according to claim 6, in the form of a tablet, wafer, capsule, coated pill or solution.
Claim 9
Dependent Claim
23 words
A method for treating epilepsy, comprising administering a psychotropic composition according to claim 1 to humans or animals in need of such treatment.